AML patients benefit from stem cell transplants

A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukemia (AML), according to a new analysis of two dozen clinical studies.read more

Read the whole article on Harvard Science

More from Harvard Science